Related Experiment Video
Updated: May 19, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
Pseudolaric acid B induces caspase-dependent apoptosis and autophagic cell death in prostate cancer cells
Jing Tong1, Shutao Yin, Yinhui Dong
1Division of Nutrition and Health, College of Food Science and Nutritional Engineering, China Agricultural University, Haidian District, Beijing, China.
Abstract:
Previous studies have shown that Pseudolaric acid B (PAB), a medicinal plant-derived terpenoid, is a promising chemopreventive or therapeutic agent against various types of cancer. However, less is known regarding its activity against prostate cancer. The objective of the current study is designed to determine the anti-prostate cancer effects of PAB. We demonstrated here that PAB was highly effective against both androgen-dependent (LNCaP) and androgen-independent prostate cancer cells (PC-3 and DU145) through the mechanisms involved in induction of G2/M cell cycle arrest, caspase-dependent apoptosis and autophagic cell death. Furthermore, PAB can greatly sensitize these two aggressive androgen-independent prostate cancer cells to ABT-737-induced cytotoxicity. Our findings suggest that PAB holds excellent potential as either novel chemopreventive agent or enhancer of therapeutic drug against prostate cancer.
Insights
Pseudolaric acid B (PAB) shows significant anti-prostate cancer effects by inducing cell death and halting cell cycle progression. This natural compound also enhances the efficacy of existing cancer therapies.
Area of Science:
- Natural Products Chemistry
- Cancer Biology
- Pharmacology
Background:
- Pseudolaric acid B (PAB), a terpenoid from medicinal plants, shows potential as a cancer chemopreventive and therapeutic agent.
- Limited data exists on PAB's efficacy against prostate cancer, necessitating further investigation.
Purpose of the Study:
- To investigate the anti-prostate cancer effects of Pseudolaric acid B (PAB).
- To elucidate the mechanisms underlying PAB's action on prostate cancer cells.
- To evaluate PAB's potential in combination therapy for prostate cancer.
Main Methods:
- In vitro studies using androgen-dependent (LNCaP) and androgen-independent (PC-3, DU145) prostate cancer cell lines.
- Analysis of cell cycle progression, apoptosis (caspase-dependent), and autophagic cell death.
- Assessment of PAB's sensitizing effect on ABT-737-induced cytotoxicity.
Main Results:
- PAB demonstrated high efficacy against both androgen-dependent and androgen-independent prostate cancer cells.
- Mechanisms of action included G2/M cell cycle arrest, caspase-dependent apoptosis, and autophagic cell death.
- PAB significantly enhanced the cytotoxicity of ABT-737 in aggressive prostate cancer cells.
Conclusions:
- PAB exhibits potent anti-prostate cancer activity through multiple cell death pathways.
- PAB shows promise as a novel chemopreventive agent for prostate cancer.
- PAB can act as a therapeutic enhancer, improving the effectiveness of existing drugs against prostate cancer.
More Related Videos
06:12LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
Published on: May 3, 2024
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis